Search research articles
Contact Us
Filters
Showing results (841-850 of 1,060) with videos related to
Page
of 106
Sort By:
Circulation. Heart Failure
|
September 16, 2015
HDACs Regulate miR-133a Expression in Pressure Overload-Induced Cardiac Fibrosis
Ludivine Renaud, Lillianne G Harris, Santhosh K Mani, et al.
The American Journal of Medicine
|
September 27, 2013
Digoxin and 30-day all-cause hospital admission in older patients with chronic diastolic heart failure
Taimoor Hashim, Shereen Elbaz, Kanan Patel, et al.
Circulation. Heart Failure
|
August 9, 2017
Health-Related Quality of Life Outcomes in PARADIGM-HF
Eldrin F Lewis, Brian L Claggett, John J V McMurray, et al.
Journal of Cardiac Failure
|
May 22, 2026
Baroreflex activation therapy in heart failure - the Barostim-Enabled Neurohormonal Intervention for Improving Treatment of Heart Failure (BENEFIT-HF) trial rationale and design
Farooq H Sheikh, William T Abraham, Philip B Adamson, et al.
The American Journal of Cardiology
|
July 13, 2019
Relation of Lymphangiogenic Factor Vascular Endothelial Growth Factor-D to Elevated Pulmonary Artery Wedge Pressure
Brian A Houston, Ryan J Tedford, Renee L Baxley, et al.
The New England Journal of Medicine
|
November 18, 2024
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
Milton Packer, Michael R Zile, Christopher M Kramer, et al.
JAMA Cardiology
|
August 30, 2024
Effects of Sacubitril/Valsartan on All-Cause Hospitalizations in Heart Failure: Post Hoc Analysis of the PARADIGM-HF and PARAGON-HF Randomized Clinical Trials
Henri Lu, Brian L Claggett, Milton Packer, et al.
Journal of Cardiac Failure
|
June 19, 2016
Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction
Parul U Gandhi, Sheryl L Chow, Thomas S Rector, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
July 5, 2014
Cardiac-restricted overexpression or deletion of tissue inhibitor of matrix metalloproteinase-4: differential effects on left ventricular structure and function following pressure overload-induced hypertrophy
William M Yarbrough, Catalin Baicu, Rupak Mukherjee, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
March 11, 2026
Modifying the structural substrate and progression of heart failure with preserved ejection fraction using a regular exercise regimen in pigs
Stephanie L Samani, Shayne C Barlow, Lisa A Freeburg, et al.
Page
of 106
Search research articles
Search
Showing results (841-850 of 1,060) with videos related to
Sort By:
Page
of 106
Circulation. Heart Failure
|
September 16, 2015
HDACs Regulate miR-133a Expression in Pressure Overload-Induced Cardiac Fibrosis
Ludivine Renaud, Lillianne G Harris, Santhosh K Mani, et al.
The American Journal of Medicine
|
September 27, 2013
Digoxin and 30-day all-cause hospital admission in older patients with chronic diastolic heart failure
Taimoor Hashim, Shereen Elbaz, Kanan Patel, et al.
Circulation. Heart Failure
|
August 9, 2017
Health-Related Quality of Life Outcomes in PARADIGM-HF
Eldrin F Lewis, Brian L Claggett, John J V McMurray, et al.
Journal of Cardiac Failure
|
May 22, 2026
Baroreflex activation therapy in heart failure - the Barostim-Enabled Neurohormonal Intervention for Improving Treatment of Heart Failure (BENEFIT-HF) trial rationale and design
Farooq H Sheikh, William T Abraham, Philip B Adamson, et al.
The American Journal of Cardiology
|
July 13, 2019
Relation of Lymphangiogenic Factor Vascular Endothelial Growth Factor-D to Elevated Pulmonary Artery Wedge Pressure
Brian A Houston, Ryan J Tedford, Renee L Baxley, et al.
The New England Journal of Medicine
|
November 18, 2024
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
Milton Packer, Michael R Zile, Christopher M Kramer, et al.
JAMA Cardiology
|
August 30, 2024
Effects of Sacubitril/Valsartan on All-Cause Hospitalizations in Heart Failure: Post Hoc Analysis of the PARADIGM-HF and PARAGON-HF Randomized Clinical Trials
Henri Lu, Brian L Claggett, Milton Packer, et al.
Journal of Cardiac Failure
|
June 19, 2016
Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction
Parul U Gandhi, Sheryl L Chow, Thomas S Rector, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
July 5, 2014
Cardiac-restricted overexpression or deletion of tissue inhibitor of matrix metalloproteinase-4: differential effects on left ventricular structure and function following pressure overload-induced hypertrophy
William M Yarbrough, Catalin Baicu, Rupak Mukherjee, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
March 11, 2026
Modifying the structural substrate and progression of heart failure with preserved ejection fraction using a regular exercise regimen in pigs
Stephanie L Samani, Shayne C Barlow, Lisa A Freeburg, et al.
Page
of 106